Tag Archives: 04/2016

Professional Education for Medical Students

Jone Trovik, portrett til disputasDid you see the medical students with their green name plates on their white coats and expectant but uncertain gazes, swarming around the various departments January 13th and 14th?

THANK YOU for taking such good care of them! I have had the pleasure of reading their reports, which confirm that they were well taken care of by the entire chain of healthcare professionals that they met: the porter who showed them the right way through the tunnel, the biomedical laboratory scientist who patiently explained that this particular instrument measured hemoglobin, the nurse who looked after the student who nearly fainted in the examination room and all the doctors who explained why they said and did everything during an entire workday.

Getting this first insight into a day at a hospital, observing lots of good interaction and seeing that we all have our place in the diagnostic and treatment chain have given them an important insight into the life of a doctor. Observation of the doctor-patient meetings without the requirement of direct academic learning provides an opportunity for good role models; this is building professionalism!

Getting their noses out of the books and into the staff and patient rooms has aroused motivation; they see that also basic knowledge is necessary to understand complex medical conditions.

The fact that the same students will be back at your department, brings confidence for both them and us. It also provides an opportunity for the individual student’s local supervisor to follow her / him over time. In that situation it will also be easier to see if a student struggles, either with acquiring academic knowledge or with personal problems.

The students describe a wide range of pleasant workplaces that take good care of the workers, which is primarily a benefit for us who work there every day. Let us continue to be attentive to each other also when we are not showing our “best side” with a student in tow.

Jone

Obituary: Helga Birgitte Salvesen

Helga

(In Norwegian)
Det er med stor sorg vi torsdag 21. januar mottok budskapet om professor og overlege Helga Birgitte Salvesens bortgang.

Helga disputerte14. juni 2000 for sin doktorgrad i medisin med avhandlingen: “Tumor Biomarkers and Prognostic Factors in Endometrial Carcinoma”. Hun var fra 1991 lege, og fra 2001 overlege, ved Kvinneklinikken, Haukeland Universitetssykehus og hun ble i 2003 professor ved UiB i gynekologi og obstetrikk.

Hun var en av våre fremste professorer og var ledende på forskning innen gynekologisk kreft. Sammen med sine kolleger har hun stått bak flere, store gjennombrudd innenfor sitt forskningsfelt. Hun var co-direktør ved Centre for Cancer Biomarkers (CCBIO) som er et Senter for fremragende forskning (SFF) ved Det medisinsk-odontologiske fakultet ved UiB, og mottok i 2015 Helse Vest forskning- og innovasjonspris for sitt enestående arbeid innen persontilpasset behandling av gynekologisk kreft. Helga ble i 2015 også innvalgt som medlem av Det Norske Videnskaps-Akademi. Hun var et spesielt godt forbilde for kvinner i akademia og jobbet aktivt for å fremme kvinnelige forskere.

Helga var spesialist innen gynekologi og obstetrikk, og hun har hatt forskningsopphold ved Harvard University, Broad Institute og University of Chicago, der forskningsfokus har vært på studier av genetiske markører i relasjon til gynekologisk kreft.

Helga har særlig arbeidet med å utvikle de mulighetene som molekylærbiologi kan gi til studiene av gynekologisk kreft. I alt har hun publisert over 130 vitenskapelige artikler og har vært veileder for en lang rekke PhD kandidater.

Det er særlig grunn til å framheve Helga sin store metodologiske bredde og angrepsvinkel i sine studier. Hun bygget i løpet av kort tid opp en stor forskningsgruppe ved Universitetet i Bergen og Haukeland universitetssykehus, der hun brakte fram det beste i disiplinoverbyggende klinisk forskning generelt og kreftforskning spesielt. Helga var en engasjert og omsorgsfull lege og forskningsleder, og ble gjennom sitt virke et forbilde for mange unge forskere og leger. Hun hadde alltid pasientenes beste for øyet. Universitetet i Bergen og Haukeland universitetssykehus er svært takknemlig for den innsats hun la ned gjennom en årrekke ved våre institusjoner og i dyp sorg over å ha mistet en fremragende medarbeider. Våre varme tanker går til Pål og sønnene Tormund, Pål-Christian, Erlend og Håvard i disse tunge dager.

Dag Rune Olsen, rektor
Nina Langeland, dekan
Eivind Hansen, administrerende direktør
Alf Henrik Andreassen, fagdirektør
Ingrid Johanne Garnes, klinikkdirektør KK
Per Bakke, instituttleder

K1/K2 Seminar 2016

We wish to invite you all to the first K1/K2 Seminar of 2016!

Title: “Therapeutic nanoparticles for delivery of anti-cancer drugs”.
Held by: Lars Herfindal, Prof., Center for Pharmacy.
When: Wednesday, February 3rd, 14:15-15:00.
Where: Main Auditorium, 3rd floor, Sentralblokken.
Chair: Svein Haavik

Pizza will be served before the seminar, from 14:05-14.15

See attachment for abstract.

Pest! Horizon lectures / Darwin Day

Welcome to the first horizon lectures of the year in collaboration with Darwin Day Bergen, and supported by the Company for the promotion of science:
Pest! – Horizon Lectures / Darwin Day with Nils Chr. Stenseth, Geir Atle Ersland and Bjørn Blomberg.
University Aula Monday February 15 From 3:40 pm there will be refreshments ahead of the lectures that start (exactly!) 4 pm. Everyone is welcome! Continue reading

Upcoming SIU announcements

SIUSIU will announce more than 200 million NKR for educational cooperation with universities in various parts of the world in 2016. In February proposals in the following programs will be announced:
Partnerskapsprogrammet, NORAM, Nordområdeprogrammet, EURASIA, INTPART, UTFORSK, CAPES-SIU and Nordisk-russisk samarbeid. Some of these have a deadline at the end of May, others in late September. More information about the programs can be found here (in Norwegian).

We will also remind you of the SIU mini-workshop on project applications which takes place ahead of the Internationalization Conference.

Cardiac Research Award to Kenneth Dickstein

Kenneth Dickstein

Kenneth Dickstein (Department of Clinical Science) is a professor at the University of Bergen (UiB) and consultant at the medical intensive care unit at Stavanger University Hospital (SUS). Kenneth Dickstein has received the Cardiac Research Award 2016 from “Nasjonalforeininga for folkehelsa”. He received the award for his crucial research contributions in cardiovascular research, and for his role in the building of their academic environment. For more information see the attached press release and UiB pages  (both in Norwegian).

 

Meeting Series in The Genomics Club

We would like to inform the members of K2 and K1 of a meeting series:
The Genomics Club is a meeting forum for people from different research groups in K1 and K2 who are working with Genomic data.
The Club meets every other Wednesday with chosen presentations, at 12.00 in the meeting room on the 6th floor (6.1-6.2 Laboratory building).
Next presentation will be Wednesday 3rd February: Christine Stansberg who will present the NORBIS research school and Bioinformatics in Bergen. (12.00 in rooms 6.1-6.2)

If you would like to join the Club and get update on the meeting schedule and meet other people working on Genomics please email Tomasz Stokowy.

New Publications

Based on last week’s search for “Department of Clinical Science AND Bergen”. If you have publications which are not covered by this search, send the reference to elin.opheim@uib.no.

Invasive versus conservative strategy in patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris (After Eighty study): an open-label randomised controlled trial.
Tegn N, Abdelnoor M, Aaberge L, Endresen K, Smith P, Aakhus S, Gjertsen E, Dahl-Hofseth O, Ranhoff AH, Gullestad L, Bendz B; After Eighty study investigators.
Lancet. 2016 Jan 12.

Challenges in psychopharmacology: a drug information centre perspective.
Schjøtt J.
J Clin Pharm Ther. 2016 Feb;41(1):4-6.

The Association of Gum Bleeding with Respiratory Health in a Population Based Study from Northern Europe.
Gómez Real F, Pérez Barrionuevo L, Franklin K, Lindberg E, Bertelsen RJ, Benediktsdóttir B, Forsberg B, Gislason T, Jögi R, Johannessen A, Omenaas E, Saure E, Schlünssen V, Skorge TD, Torén K, Pérez Saavedra A, Svanes Ø, Åstrøm AN, Janson C, Svanes C.
PLoS One. 2016 Jan 25;11(1):e0147518.

Prolonged Dye Release from Mesoporous Silica-Based Imaging Probes Facilitates Long-Term Optical Tracking of Cell Populations In Vivo.
Rosenholm JM, Gulin-Sarfraz T, Mamaeva V, Niemi R, Özliseli E, Desai D, Antfolk D, von Haartman E, Lindberg D, Prabhakar N, Näreoja T, Sahlgren C.
Small. 2016 Jan 25.

B vitamin treatments modify the risk of myocardial infarction associated with a MTHFD1 polymorphism in patients with stable angina pectoris.
Ding YP, Pedersen EK, Johansson S, Gregory JF 3rd, Ueland PM, Svingen GF, Helgeland Ø, Meyer K, Fredriksen Å, Nygård OK.
Nutr Metab Cardiovasc Dis. 2015 Dec 23.

Metabolomics study of fatigue in patients with rheumatoid arthritis naïve to biological treatment.
Surowiec I, Gjesdal CG, Jonsson G, Norheim KB, Lundstedt T, Trygg J, Omdal R.
Rheumatol Int. 2016 Jan 23.

Assessing Early Life Factors for Eosinophilic Esophagitis: Lessons From Other Allergic Diseases.
Jensen ET, Bertelsen RJ.
Curr Treat Options Gastroenterol. 2016 Jan 23.

Expert opinion of mediastinal lymph node positions from an intrabronchial view.
Roth K, Eagan T, Hardie J.
BMC Pulm Med. 2016 Jan 22;16(1):15.

Co-transplantation of multipotent mesenchymal stromal cells in allogeneic hematopoietic stem cell transplantation: A systematic review and meta-analysis.
Kallekleiv M, Larun L, Bruserud Ø, Hatfield KJ.
Cytotherapy. 2016 Feb;18(2):172-85.

Serum Markers in Rheumatoid Arthritis: A Longitudinal Study of Patients Undergoing Infliximab Treatment.
Selaas O, Nordal HH, Halse AK, Brun JG, Jonsson R, Brokstad KA.
Int J Rheumatol. 2015;2015:276815.

Mutations in TP53 increase the risk of SOX2 copy number alterations and silencing of TP53 reduces SOX2 expression in non-small cell lung cancer.
Samulin Erdem J, Skaug V, Bakke P, Gulsvik A, Haugen A, Zienolddiny S.
BMC Cancer. 2016 Jan 19;16(1):28.